Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell D Hull

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Archives of Internal Medicine|May 28, 2003
Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolismPaul D Stein, Russell D Hull, William A Ghali, et al.
Thrombosis and Haemostasis|May 12, 2005
Fatal vascular outcomes following major orthopedic surgeryOla E Dahl, Joseph A Caprini, Clifford W Colwell, et al.
Journal of Thrombosis and Haemostasis : JTH|August 9, 2019
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or moreWalter Ageno, Renato D Lopes, Megan K Yee, et al.
American Journal of Hematology|September 26, 2018
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trialGerald Chi, C Michael Gibson, Yuyin Liu, et al.
The New England Journal of Medicine|May 28, 2016
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical PatientsAlexander T Cohen, Robert A Harrington, Samuel Z Goldhaber, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 8, 2019
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US HospitalsAnne-Céline Martin, Wei Huang, Samuel Z Goldhaber, et al.
Stroke|November 3, 2012
Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM studyAlexander G G Turpie, Russell D Hull, Sebastian M Schellong, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM studyRussell D Hull, Sebastian M Schellong, Victor F Tapson, et al.
The American Journal of Cardiology|March 10, 2009
Diagnosis of pulmonary embolism in the coronary care unitPaul D Stein, H Dirk Sostman, Russell D Hull, et al.
The American Journal of Medicine|July 6, 2004
Venous thromboembolism in pregnancy: 21-year trendsPaul D Stein, Russell D Hull, Fadi Kayali, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Archives of Internal Medicine|May 28, 2003
Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolismPaul D Stein, Russell D Hull, William A Ghali, et al.
Thrombosis and Haemostasis|May 12, 2005
Fatal vascular outcomes following major orthopedic surgeryOla E Dahl, Joseph A Caprini, Clifford W Colwell, et al.
Journal of Thrombosis and Haemostasis : JTH|August 9, 2019
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or moreWalter Ageno, Renato D Lopes, Megan K Yee, et al.
American Journal of Hematology|September 26, 2018
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trialGerald Chi, C Michael Gibson, Yuyin Liu, et al.
The New England Journal of Medicine|May 28, 2016
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical PatientsAlexander T Cohen, Robert A Harrington, Samuel Z Goldhaber, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 8, 2019
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US HospitalsAnne-Céline Martin, Wei Huang, Samuel Z Goldhaber, et al.
Stroke|November 3, 2012
Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM studyAlexander G G Turpie, Russell D Hull, Sebastian M Schellong, et al.
Journal of Thrombosis and Thrombolysis|June 21, 2006
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM studyRussell D Hull, Sebastian M Schellong, Victor F Tapson, et al.
The American Journal of Cardiology|March 10, 2009
Diagnosis of pulmonary embolism in the coronary care unitPaul D Stein, H Dirk Sostman, Russell D Hull, et al.
The American Journal of Medicine|July 6, 2004
Venous thromboembolism in pregnancy: 21-year trendsPaul D Stein, Russell D Hull, Fadi Kayali, et al.
Pageof 13